Article Text

Download PDFPDF
Neurofibromatosis type 1 first presented as hypertensive crisis
  1. Shuo Xi1,
  2. Haleem Mohammed Abdul2 and
  3. Surjit Tarafdar2
  1. 1Neurology, Blacktown Hospital, Blacktown, New South Wales, Australia
  2. 2Nephrology, Blacktown Hospital, Blacktown, New South Wales, Australia
  1. Correspondence to Dr Shuo Xi; shuo.xi{at}health.nsw.gov.au

Abstract

Neurofibromatosis type 1 (NF1) is known to cause vascular complications including stenotic and aneurysmal disease. Here, we report a case of a woman in her early 20s, who presented with unilateral facial nerve palsy and hypertensive crisis, and was later found to have multiple bilateral intrarenal microaneurysms along with classic cutaneous manifestations of NF1. A causal relationship between the pathophysiology of NF1 and the development of renal artery microaneurysm and hypertension is proposed in this case report.

  • Neurology
  • Renal medicine
  • Hypertension

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors SX: diagnosis of reported case (equal), writing original draft (lead), literature review (lead), reviewing and editing of draft (lead), conceptualisation of case report (equal). HMA: writing, reviewing and editing of draft (supporting), conceptualisation of case report (equal). ST: conceptualisation of case report (equal), writing, reviewing and editing of draft (supporting)

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.